Skip to main content
. 2023 Jun 20;57(1):e13522. doi: 10.1111/cpr.13522

FIGURE 6.

FIGURE 6

Overexpression of Wnt10b enhanced the osteogenic ability of OP‐ASCs in vivo. (A) H&E and Masson staining of composite scaffolds containing modified OP‐ASC and BCP in mice after 4/8/12 weeks of implantation. (B) Immunohistochemical staining specific for osteopontin (Opn) of composite scaffolds. Arrows indicate new bone in (A) and OPN deposition in (B), n = 3 for each group. BCP, biphasic calcium phosphate; H&E, haematoxylin and eosin; OP‐ASC, osteoporotic adipose‐derived stem cell.